FDA
approval
· 2024-10-31
FDA Approved: EDARAVONE — Original Application (XGen Pharmaceuticals DJB, Inc.)
Summary
The FDA approved the Original Application for edaravone from XGen Pharmaceuticals DJB, Inc., enabling a generic version of the ALS therapy to reach the U.S. mar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EDARAVONE (EDARAVONE)